Literatur
- 1
Carlsson R, Dent J, Watts R. et al. International GORD Study Group .
Gastro-oesophageal reflux disease in primary care: An international study of different
treatment strategies with omeprazole.
Eur J Gastroenterol Hepatol.
1998;
10
119-124
- 2
Castell D O, Kahrilas P J, Richter J E, Vakil N B, Johnson D A, Zuckermann S, Skammer W,
Levine J.
Esomeprazole (40 mg) compared with Lansoprazole (30 mg) in the treatment of erosive
esophagitis.
Am J Gastroenterol.
2002;
3
575-583
- 3
Chiba N, De Gara C J, Wilkinson J M.
Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease:
a meta-analysis.
Gastroenterology.
1997;
112
1798-810
- 4
Corley D A, Levin T R, Habel L A. et al .
Surveillance and survival in BarrettŽs adenocarcinoma: a population-based study.
Gastroenterology.
2002;
122
633-640
- 5
Dent J, Brun J, Fendrick A. et al .
An evidence-based appraisal of reflux disease management - the Geneval Workshop
report.
Gut.
1999;
44
S1-S16
(suppl 2)
- 6
Edwards S J, Lind T, Lundell L.
Systematic review of proton pump inhibitors for the acute treatment of reflux esophagitis.
Aliment Pharmacol Ther.
2001;
15
1729-1736
- 7
El Serag H B, Sonnenberg A.
Opposing trends of peptic ulcer and reflux disease.
Gut.
1998;
43
327-333
- 8
Holloway R H, Dent J, Narielvala F, Mackinnon A M.
Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole
in patients with severe reflux oesophagitis.
Gut.
1996;
38
649-654
- 9
Lundell L.
Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux
disease. Protagonist.
Gut.
2002;
51
468-471
- 10
Lundell L, Miettinen P, Myrvold H E. et al .
Continued (5-year) follow up of a randomised clinical study comparing antireflux
surgery and omeprazole in gastroesophageal reflux disease.
J Am Coll Surg.
2001;
192
172-179
- 11
Malfertheiner P, Leodolter A, Vieth M, Jaspersen D, Labenz J, Meyer-Sabellek W, Kulig M,
Willich S t, Lind T, Stolte M.
Which factors have an impact on healing and symptom relief in patients with erosive
and non-erosive GERD treated with esomeprazole? An analysis based on the ProGERD
study initiative (abstract).
DDW.
2002;
A192
S1283
- 12
Menges M, Muller M, Zeitz M.
Increased acid and bile reflux in BarrettŽs esophagus compared to reflux esophagitis,
and effect of proton pump inhibitor therapy.
Am J Gastroenterol.
2002;
97
207
- 13
Orlando R C.
The pathogenesis of gastroesophageal reflux disease: The relationsship between epithelial
defense, dysmotility, and acid exposure.
Am J Gastroenterol.
1997;
92
3S-7S
- 14
Richter J E, Kahrilas P J, Johanson J. et al .
Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with
erosive esophagitis: a randomised controlled trial.
Am J Gastroenterol.
2001;
96
656-665
Prof. Dr. med. Peter Malfertheiner
Zentrum Innere Medizin, Otto-von-Guericke-Universität
Leipziger Straße 44
39120 Magdeburg
